)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Aurobindo Pharma
Aurobindo Pharma (AUROPHARMA) investor relations material
Aurobindo Pharma Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary10 Feb, 2026
Executive summary
Q3FY26 revenue reached ₹8,646 crore, up 8.4% year-over-year, driven by strong Europe and stable US performance, with net profit at ₹910 crore and EPS at ₹15.67, up 7.7% YoY.
Standalone and consolidated unaudited financial results for Q3 and nine months ended December 31, 2025, were approved and reviewed without qualification by auditors.
Strategic initiatives include ramping up Pen G production, expanding manufacturing footprint, executing bolt-on acquisitions, and expanding biosimilars portfolio.
Free cash flow of $118 million generated in the quarter, with net cash (including investments) at $251 million after the Khandelwal Labs acquisition.
Investment of ₹66 crores for a 26% stake in Garuda Renewables Private Limited to procure renewable energy.
Financial highlights
Revenue from operations grew 8.4% YoY and 4.3% sequentially; gross profit margin improved by 129 bps YoY to 59.7%.
Net profit for the period was INR 910 crore, after a one-time labor code amendment cost of INR 65 crore.
EBITDA margin stood at 20.5%, up 11 bps YoY; net profit margin improved to 10.5%.
R&D spend was ₹409 crore (4.7% of sales), focused on biosimilars and specialty products.
Net cash position at $251 million as of Dec 2025, after acquisition-related outflows.
Outlook and guidance
Annualized Pen G production expected to exceed 10,000 metric tons over the next 12 months, with yields improving.
Strategic focus on expanding biosimilars portfolio, with multiple launches and regulatory filings planned through 2026.
EBITDA margin target set at 20%-21% for FY 2026, with strong earnings growth visibility.
Power purchase agreement with Garuda Renewables expected to reduce power costs and improve ESG profile.
Growth to be driven by differentiated product portfolio, complex generics, and new product launches.
Lannett acquisition: expected completion timeline?
Quantify power cost savings from Garuda investment.
Labour Codes: recurring impact on employee benefits?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Aurobindo Pharma earnings date
Q4 202630 May, 2026
Aurobindo Pharma
Next Aurobindo Pharma earnings date
Q4 202630 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Aurobindo Pharma Limited is an Indian pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of generic medicines. The company’s product portfolio includes antibiotics, antiretrovirals, cardiovascular drugs, central nervous system agents, gastroenterology products, and anti-allergics, among others. Aurobindo Pharma serves markets globally, supplying generic pharmaceuticals to hospitals, pharmacies, and healthcare providers. The company also produces active pharmaceutical ingredients (APIs) and has expanded into specialty drugs and biosimilars. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage